Volume 1 - Issue 2 (October -December 2021)
“DURYSTA” the first biodegradable sustained release implant for the treatment of open-angle glaucoma
Article DOI: 10.53294/ijfbpr.2021.1.2.0042DOI url: https://doi.org/10.53294/ijfbpr.2021.1.2.0042
Designing HSP90 inhibitor drugs against mutations profiles of cancer patients
Article DOI: 10.53294/ijfbpr.2021.1.2.0045DOI url: https://doi.org/10.53294/ijfbpr.2021.1.2.0045
Coronavirus: A current update based on evidence
Article DOI: 10.53294/ijfbpr.2021.1.2.0044DOI url: https://doi.org/10.53294/ijfbpr.2021.1.2.0044